Market Cap: $1.8B
GC
GeneDx Holdings Corp.
WGS
NASDAQ (NASDAQ Global Market)USD
Market Cap: $1.8B
GeneDx Holdings Corp. ( WGS ) is currently at a critical juncture, grappling with significant financial challenges following a staggering decline in stock value, triggered primarily by disappointing e…
GeneDx Holdings Corp. WGS is currently facing a profound challenge as it navigates the aftermath of a significant stock price decline and a tumultuous financial landscape triggered by recent earnings…
GeneDx Holdings Corp. ( WGS ) finds itself at a critical juncture as the company navigates the aftermath of a staggering 49% decline in stock price that has left investors unsettled. This downturn was…
GeneDx Holdings Corp. ( WGS ) is facing significant upheaval in its operations following a sharp decline in stock value that has left investors questioning the future viability of the company. This si…
GeneDx Holdings Corp. ( WGS ) is currently grappling with a critical juncture in its business operations following a staggering 49% drop in its stock price. This decline, attributed to a series of fin…
GeneDx Holdings Corp. ( WGS ) is navigating turbulent waters following a significant downturn in its stock, resulting from financial struggles and a controversial acquisition. Over the past months, th…
GeneDx Holdings Corp. WGS is currently grappling with significant challenges as it faces a tumultuous financial landscape following a shocking 49% decline in stock price. This turn of events has been…
GeneDx Holdings Corp. ( WGS ) is confronting a challenging landscape in the genetic testing market due to a significant financial setback that has rattled investor confidence. Following an alarming 49…
GeneDx Holdings Corp. WGS has found itself grappling with unprecedented challenges following a stark financial downturn. In the wake of its recent quarterly earnings report, which revealed a calamitou…
GeneDx Holdings Corp. ( WGS ) is drawing attention as the latest developments come into focus. GeneDx Holdings Corp. (WGS) is currently navigating through turbulent waters as a result of a significant…
GeneDx Holdings Corp. ( WGS ) is currently facing significant turmoil following a calamitous decline in its stock price, which plummeted by 49% on May 5, 2026. The catalyst for this dramatic fall was…
GeneDx Holdings: Pioneering Growth in Genetic Testing GeneDx Holdings stands out as a leading player in the rapidly expanding genetic testing industry, experiencing remarkable growth that reflects its…
GeneDx: Leading the Charge in Genetic Testing Innovation GeneDx is rapidly establishing itself as a frontrunner in the genetic testing industry, showcasing remarkable growth and innovation. The compan…
GeneDx Launches ultraRapid Whole Genome Sequencing for Neonatal Care GeneDx Holdings, a leader in genomic healthcare solutions, introduces its ultraRapid Whole Genome Sequencing service aimed at neona…
GeneDx Pioneers Rapid Genetic Testing for Neonatal Care GeneDx Holdings, a leader in genomic insights, is set to transform the landscape of neonatal and pediatric healthcare with the launch of its ult…
GeneDx Enhances Genetic Testing Through Epic's Aura Integration GeneDx Holdings, a prominent player in genomic insights, has recently launched its services on Epic’s specialty diagnostics platform, Au…
GeneDx Enhances Genetic Testing through Epic Integration GeneDx Holdings, a leader in genomic insights, recently advances the field of genetic diagnostics by launching its services on Epic’s specialty…
GeneDx Prepares to Showcase Advances in Genomic Health Solutions GeneDx Holdings, a leading company in genomic insights aimed at improving health outcomes, gears up to announce its financial results f…
GeneDx Holdings Strengthens Leadership with Strategic Hiring Initiatives GeneDx Holdings Corp., a leading entity in genomic insights and personalized medical care, enhances its executive team by grant…
GeneDx Holdings: Pioneering Advances in Genetic Testing and Rare Disease Diagnosis GeneDx Holdings Corp. is experiencing a significant transformation as it reports preliminary financial results for th…
GeneDx Holdings Sees Significant Growth in Genetic Testing Services GeneDx Holdings Corp. (Nasdaq: WGS) marks a pivotal moment in its journey with the release of preliminary financial results for the…
GeneDx Launches Telehealth Pathway to Transform Genetic Testing Access GeneDx Holdings, a leader in genomic insights, has recently introduced a new telehealth testing pathway designed to enhance acces…
GeneDx Launches Innovative Telehealth Testing Pathway to Enhance Genetic Counseling Access GeneDx Holdings, a leader in genomic insights, introduces a new telehealth testing pathway aimed at improving…
GeneDx Appoints Bryan Dechairo as Chief Operating Officer to Drive Growth and Innovation GeneDx Holdings, a prominent player in genomic insights aimed at enhancing health outcomes, announces the appoi…
GeneDx Appoints Bryan Dechairo as Chief Operating Officer to Drive Operational Excellence GeneDx Holdings, a prominent player in the field of genomic insights, announces the appointment of Bryan Decha…
GeneDx Advances Genomic Insights at Major Healthcare Conference GeneDx Holdings, a leader in genomic insights, is set to showcase its commitment to personalized medicine at the upcoming 43rd Annual J.…
GeneDx Holdings Prepares for Insightful Presentation at J.P. Morgan Healthcare Conference GeneDx Holdings, a leader in genomic insights dedicated to improving health outcomes, announces its participat…
GeneDx Launches Patient Access Program to Transform Pediatric Epilepsy Diagnosis GeneDx Holdings has recently unveiled a groundbreaking Patient Access Program aimed at revolutionizing the diagnosis of…
Breaking Barriers in Pediatric Epilepsy Diagnosis: GeneDx Launches Patient Access Program GeneDx Holdings, a prominent player in genomic insights, recently announces the launch of a Patient Access Pro…
GeneDx Showcases Commitment to Genomic Innovation at Upcoming Healthcare Conference GeneDx Holdings, a prominent player in the realm of genomic insights, prepares for its participation in the Piper Sa…
GeneDx Unveils GeneDx Discover: A Game-Changer for Drug Development GeneDx Holdings, a frontrunner in genomic insights, has launched GeneDx Discover, a cutting-edge data visualization tool specificall…
GeneDx Strengthens Leadership with Appointment of Heidi Chen as Chief Legal Officer GeneDx Holdings, a prominent player in genomic insights focused on improving health outcomes, announces the appointm…
Heidi Chen Joins GeneDx as Chief Legal Officer: A Strategic Move for Future Growth GeneDx Holdings, a prominent player in the genomic insights sector, announces the appointment of Heidi Chen as its ne…
GeneDx Tackles Racial Disparities in Genetic Diagnosis Access GeneDx, a prominent player in genomic health insights, recently unveils findings that address critical racial disparities in access to gen…
GeneDx Tackles Racial Disparities in Genetic Diagnosis Access GeneDx Holdings, a frontrunner in genomic health insights, recently unveils findings from a pivotal study aimed at addressing racial dispa…
GeneDx Showcases Groundbreaking Research at ASHG 2024 GeneDx Holdings, a frontrunner in genomic insights aimed at improving health outcomes, makes a significant impact at the 2024 American Society of…
GeneDx Advances Genomic Research at ASHG 2024 GeneDx Holdings, a frontrunner in genomic insights, showcases its pivotal scientific advancements at the 2024 American Society of Human Genetics (ASHG) an…